STROMUSC Premium Andarine S4 25mg For Bodybuilding CAS:401900-40-1

   What is Andarine S4?

    Andarine S4 is a first-generation SARM originally developed by GTx, Inc. for therapeutic purposes, including the treatment of muscle-wasting conditions (cachexia), osteoporosis, and benign prostatic hyperplasia. Its design was a breakthrough in androgen receptor pharmacology. Unlike traditional anabolic steroids, which bind promiscuously to androgen receptors throughout the body, S4 was engineered for selectivity. Its molecular structure allows it to bind with high affinity to receptors in bone and muscle tissue, while exhibiting markedly lower affinity for receptors in the prostate and sebaceous glands. This theoretical selectivity is the cornerstone of its appeal, proposing anabolic benefits while mitigating classic steroidogenic side effects like severe androgenic activity and estrogenic conversion.

    The defining features of Andarine S4 stem from its precise pharmacodynamics:

    1.High Selectivity, Partial Agonism: S4 is not a full agonist. It partially activates the androgen receptor in target tissues, which can yield anabolic effects. However, this partial agonism is tissue-dependent. In organs like the prostate, it may even act as a mild antagonist, blocking the receptor and preventing overstimulation-a key feature in its therapeutic design.

    2.The "Andarine Vision" Phenomenon: This is S4's most notorious and unique characteristic. Users frequently report a transient visual disturbance, often described as a yellowish tint, difficulty adjusting from light to dark environments, or a perception of increased brightness. This occurs because S4, despite its selectivity, can temporarily affect androgen receptors in the rods of the retina. This effect is dose-dependent and almost universally reversible upon cessation, serving as a tangible, if unintended, biofeedback mechanism.

    3.Non-Steroidal Structure: As a non-steroidal ligand, S4 bypasses the 5-alpha reductase and aromatase pathways. This means it does not convert to a more potent androgen (like DHT) nor does it aromatize into estrogen. Consequently, users do not experience estrogen-related side effects such as gynecomastia or water retention, making it a popular choice for "dry" gains.

    4.Rapid Action and Clearance: S4 has a relatively short half-life (approx. 4-6 hours), necessitating split dosing. This allows for rapid modulation of its effects and quicker clearance from the system compared to longer-acting compounds.

    Given its profile, Andarine S4 is not typically viewed as a bulking agent for sheer mass. Its applications are more nuanced:

    ●The Precision Cutting Agent: S4 excels during fat-loss phases. Its ability to promote lean tissue preservation-or even modest growth-in a caloric deficit is its premier application. The lack of water retention promotes a hard, vascular, and defined physique, making it a pre-contest favorite.

    ●Recomposition Catalyst: For individuals seeking simultaneous fat loss and muscle gain, S4 can be a potent tool. When combined with a precise, protein-rich diet and rigorous training, it can shift the body's composition favorably, enhancing muscle-to-fat ratio without significant scale weight change.

    ●Strength-Promoting Agent: Users consistently report notable increases in strength and training endurance. This is likely due to its effect on the central nervous system and muscle tissue, allowing for more intense, voluminous workouts that drive adaptation. The strength gains are often disproportionate to the amount of mass added, a key distinguishing trait.

    ●A Gateway SARM: Due to its moderate potency and well-documented effects profile, it is often one of the first SARMs incorporated into a user's protocol, either as a standalone or as part of a beginner stack.

    The benefits align closely with its pharmacological design:

    ●Quality Muscle Accretion: Gains are typically lean, dense, and devoid of subcutaneous fluid.

    ●Enhanced Muscular Definition and Vascularity: The diuretic-like effect and fat loss contribute to increased vascularity and muscle separation.

    ●Significant Strength Enhancement: Facilitates progressive overload, a fundamental driver of hypertrophy.

    ●Joint Strengthening: Androgen receptors in connective tissue may be positively affected, potentially improving joint integrity and reducing discomfort under heavy loads.

    ●Absence of Estrogenic Side Effects: No risk of gynecomastia or estrogenic water bloat.

    ●Oral Bioavailability: Does not require injection.

    ●Dosage: The 25mg/day mark is a standard research point. However, due to its short half-life, this is optimally split into two doses of 12.5mg each, taken approximately 8-10 hours apart. Some advanced protocols may escalate to 50-75mg/day, but this significantly increases the likelihood and severity of visual side effects. A common approach is to begin at 25mg/day to assess individual tolerance.

    ●Cycle Length: Given its hepatotoxic potential (though lower than many oral steroids), cycle length should be controlled. A typical cycle lasts 8 weeks. Some extend to 12 weeks, but this requires vigilant monitoring of liver enzymes and overall health markers. Longer cycles exacerbate the risk of negative feedback on the endogenous hypothalamic-pituitary-gonadal (HPG) axis.

    ●Half-Life: Approximately 4-6 hours. This short half-life is why split dosing is critical for stable blood levels and consistent effect. It also means the compound clears the system relatively quickly after the final dose.

    ●The "5-on, 2-off" Protocol: A unique strategy historically employed with S4 involves taking the compound for five consecutive days, followed by two days off. This was theorized to help manage receptor desensitization and mitigate visual sides. While its efficacy is anecdotal, it highlights the user-base's adaptive approaches to managing the compound's peculiarities.

    The myth that SARMs are entirely free of suppressive effects is dangerously inaccurate. Andarine S4, as an androgen receptor agonist, will provide negative feedback to the HPG axis, reducing the body's natural luteinizing hormone (LH) and follicle-stimulating hormone (FSH) production, leading to suppressed natural testosterone synthesis.

    The necessity and extent of PCT depend on cycle dosage, duration, and individual response. For a conservative 8-week cycle at 25mg/day, a mild PCT is often recommended to restore endogenous function efficiently. This typically involves a SERM (Selective Estrogen Receptor Modulator) like Nolvadex (Tamoxifen Citrate) or Clomid (Clomiphene Citrate) for a period of 3-4 weeks. A sample protocol might be:

    ●Nolvadex: 20mg/day for weeks 1-2, 10mg/day for weeks 3-4.

    ●Clomid: 25mg/day for 3-4 weeks.

    PCT should only commence after S4 has cleared the system, typically 3-5 days after the last dose. Blood work (testosterone, LH, FSH, lipids, liver enzymes) before, during, and after a cycle is the only objective way to determine suppression levels and PCT efficacy.

    ●Vision Side Effects: The most common and unique drawback. While usually temporary, it can be disconcerting and potentially hazardous for activities like night driving.

    ●Testosterone Suppression: Varies by individual but is a guaranteed outcome at bodybuilding doses. Without proper PCT, recovery can be slow, leading to loss of gains and low-T symptoms.

    ●Hepatotoxicity: While considered less stressful than oral alkylated steroids, S4 is still a 17-alpha alkylated compound to ensure oral bioavailability. It imposes strain on the liver, necessitating cycle limits and consideration of liver support supplements.

    ●Lipid Profile Impact: Like most androgenic compounds, it can negatively alter cholesterol levels, suppressing HDL ("good" cholesterol) and potentially elevating LDL ("bad" cholesterol).

    ●Legality and Purity: In many jurisdictions, SARMs are not approved for human consumption and are sold as "research chemicals." This unregulated market poses severe risks of under-dosing, mislabeling, or contamination.

Brand	STROMUSC
Trade names	Acetamidoxolutamide; Androxolutamide; GTx-007; S-4
CAS	401900-40-1
Molar mass	441.363
Formula	C19H18F3N3O6
Purity	Above 98%
Apprarance	25mg*100

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

    Andarine S4 25mg represents a fascinating chapter in the pursuit of targeted anabolic agents. It is not a mass-building monster but a precision instrument for hardening, strengthening, and preserving lean tissue under metabolically demanding conditions. Its signature visual effect serves as a constant reminder of its biological activity and the inherent trade-offs in pharmacological enhancement.

    The modern bodybuilder must approach it with respect for its potency and a clear understanding of its mechanisms. Its value lies in specific applications-cutting and recomposition-where its profile of dry gains, strength promotion, and manageable (if peculiar) side effects can be leveraged effectively. Ultimately, its use demands a commitment to rigorous research, meticulous cycle planning, comprehensive health monitoring, and a disciplined post-cycle strategy to safeguard long-term physiological health. It remains a compound for the informed, not the casual, emphasizing that in bodybuilding, selectivity often comes with its own unique set of compromises.

Hot Tags: stromusc premium andarine s4 25mg for bodybuilding cas:401900-40-1, China stromusc premium andarine s4 25mg for bodybuilding cas:401900-40-1 manufacturers, suppliers, factory, S23, Andarine S4 Build muscle, YK11 The strongest SARM for muscle gain, LGD4033, AC-262, LGD3303